The prostate health index (PHI) is a blood test that more accurately assesses the risk of prostate cancer than a traditional PSA test. The PHI combines three different PSA tests to create one risk ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

Dr. Brawley answers the question: 'Reasons To Not Test For Prostate Cancer?' March 16, 2009 -- Question: Are there any arguments against screening for prostate cancer? Answer: Screening for prostate ...

To the Editor: In the BARCODE1 study, McHugh et al. (April 10 issue) 1 assessed the use of a polygenic risk score in prostate cancer screening, concluding that more clinically significant cases were ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Prostate cancer kills around 3,900 Australians a year.

John Taylor, 69, was denied a PSA blood test despite repeated urinary symptoms - Paul Cooper I didn’t know anything about prostate cancer when I first went to the doctor’s. I’d started noticing that I ...

Prostate cancer can be difficult to detect in its beginning stages — here's what to look out for Getty Prostate cancer is one of the most common types of cancer in males. It starts in the prostate, a ...

Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...